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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A320intra-articular injection of monoiodoacetate (MIA), and the joint
degeneration was assessed with the OARSI cartilage degeneration score
in histological assessments of the joints of the rats.
Results: The MCP-1 itself enhanced the autocrine of MCP-1 in OA and
normal human cartilage and the Expression of collagen I, V, IX, XI and
Matrix metalloproteinases (MMP) increased after Stimulation of MCP-1.
The MCP-1 also induced the apoptosis of normal and OA chondrocytes.
The CCR-2 antagonist retarded the establishment of a monoiodoacetate
(MIA)-induced animal model of OA in rats.
Conclusions: The results of this study prove that the MCP-1-CCR2
ligand-receptor axis plays an important role in the progress of the OA's
pathology. Inhibition of the MCP-1-CCR2 ligand-receptor axis may
retard the pathological progress of human OA. And, we speculate that
lots of OA patients that etiology is unclear can gain some cues from the
MCP-1-CCR2 ligand-receptor axis, according to our present study.
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BONE GEOMETRY OF THE HIP IS ASSOCIATED WITH OBESITY AND
EARLY STRUCTURAL DAMAGE e A 3.0T MRI STUDY OF
COMMUNITY-BASED ADULTS
A. Teichtahl y, Y. Wang z, S. Smith z, A. Wluka z, M. Zhu z, D. Urquhart z,
G. Giles x, R. O'Sullivan z, F. Cicuttini z. yBaker IDI/Monash Univ.,
Melbourne, Australia; zMonash Univ., Melbourne, Australia; xCancer
Council Victoria, Melbourne, Australia
Purpose: The mechanism by which obesity increases the risk of hip
osteoarthritis (OA) is unclear. One mechanism may be by mediating
abnormalities in bony geometry, which may in turn be associated with
early structural abnormalities, such as cartilage defects and bone mar-
row lesions (BMLs).
Methods: 141 older adults with no diagnosed hip OA had weight and
body mass index (BMI) measured between 1990 and 1994 and again in
2009-10. Acetabular depth and lateral centre edge angle (LCEA), both
measures of acetabular over-coverage, as well as femoral head cartilage
volume, cartilage defects and BMLs were assessed with 3.0T MRI per-
formed in 2009-10.
Results: Current BMI, weight and weight gain were associated with
increased acetabular depth and LCEA (all p  0.01). For every one mil-
limetre increase in acetabular depth, femoral head cartilage volume
reduced by 59mm3 (95% CI 98mm3 to 20mm3, p < 0.01). Greater ace-
tabular depth was associated with an increased risk of cartilage defects
(OR 1.22, 95% CI 1.03e1.44, p ¼ 0.02) and BMLs (OR 1.29, 95% CI
1.01e1.64, p ¼ 0.04) in the central region of the femoral head. LCEAwas
not associated with hip structure.
Conclusions: Obesity is associated with acetabular over-coverage.
Increased acetabular depth, but not the LCEA, is associated with
reduced femoral head cartilage volume and an increased risk of carti-
lage defects and BMLs. Minimising any deepening of the acetabulum,
for example through weight management, might help to reduce the
incidence of hip OA.
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THE BENEFICIAL ROLE OF PAI-1 IN BONE-CARTILAGE INTERACTION
M.F. Pustjens y, S.C. Mastbergen y, W.H. Noort-Van der Laan z,y,
R.J. Van Heerwaarden z, F.P. Lafeber y. yUniv. Med. Ctr. Utrecht, Utrecht,
Netherlands; z St. Maartenskliniek, Woerden, Netherlands
Purpose: In osteoarthritis (OA) subchondral bone changes are seen in
addition to cartilage changes. In treatments targeted at bone, such as
treatment with strontium ranelate (Reginster, 2013), or treatments with
bone involvement such as osteotomy (Jung et al, 2014) or joint dis-
traction (Intema et al, 2012) cartilage repair has been demonstrated.
These studies support the hypothesis that a reset of bone can lead to
cartilage repair. However, the exact biochemical interactions and how
this contributes to repair and degradation processes is less well known.
Plasminogen activator inhibitor (PAI)-1, inhibits plasmin which
accounts for higher levels of MMPs in OA. It is expressed in subchondral
bone and cartilage. The present study evaluates the role of plasminogen
activator inhibitor 1 (PAI-1) in bone-cartilage interaction and its direct
effects on osteoarthritic cartilage.
Methods: Osteoblast culture supernatant from healthy (n¼14) and OA
(n¼16) donors was tested on both healthy and OA cartilage and pro-
teoglycan (PG) synthesis was studied. Expression levels of mediators
were assessed in the osteoblast culture supernatants by Luminexanalysis. Subsequently, OA cartilage (n¼11 donors) was cultured in
absence/presence of PAI-1 and PG synthesis changes were studied.
Results: PG synthesis of OA cartilage was increased (þ34%, p¼0.036)
upon addition of healthy osteoblast supernatant. Importantly, a
decrease was seen when OA osteoblast supernatant was added to
healthy cartilage (-31% PG synthesis, p¼0.001). PAI-1 was expressed at
signiﬁcant higher levels in healthy osteoblasts compared to OA osteo-
blasts (184ng/ml vs 91ng/ml, resp.p¼0.015). Moreover, osteoblast PAI-1
levels were positively correlated with PG synthesis (r¼0.595, p¼0.042)
inﬂuenced by the osteoblasts. Culturing OA cartilage in direct presence
of PAI-1 (2000ng/ml) revealed 33% (p¼0.026) increase of PG synthesis
conﬁrming the beneﬁcial role of PAI-1 in the osteoblast cultures.
Conclusions: Healthy osteoblast derivedmediators lead to PG synthesis
increase in OA cartilage, while it has no effect on healthy cartilage.
Moreover, OA osteoblast derived mediators lead to a decrease in PG
synthesis in healthy cartilage, but not in OA cartilage. Higher PAI-1
levels in these osteoblasts cultures are clearly correlated with higher PG
synthesis in cartilage, which hints at a role for PAI-1 in cartilage repair.
Its direct effects on OA cartilage, increasing PG synthesis, further con-
ﬁrmed the relevance of PAI-1. This supports that targeting bone directly
or involvement of bone might be feasible as treatment for OA.
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INVOLVEMENT OF TGFß1 IN THE INITIAL PHASE OF TMJ AND KNEE
OSTEOARTHRITIS
E.M. Long, R.E. Seegmiller, P. Reynolds. Brigham Young Univ., Provo, UT,
USA
Purpose: The objective of this study was to elucidate OA progression in
an animal model of Stickler syndrome by assessing the expression of an
identiﬁed inﬂammatory marker associated with OA, viz., TGFß1. The
study provides potential mechanistic insight into disease progression
based on the temporal expression of TGFß1 in knee and tempor-
omandibular joints (TMJ).
Methods: The study involved mice carrying the autosomal semi-
dominant disproportionate micromelia (Dmm/þ) mutation in the C-
propeptide coding region of the Col2a1 gene. Speciﬁcally, six wild type
control (þ/þ) and six heterozygous (Dmm/þ) mice were evaluated for
each joint. The mice were euthanized at three, six, and nine months of
age, and their TMJs and knee joints were isolated, ﬁxed, decalciﬁed,
embedded in parafﬁn, and sectioned at 6mm thickness. Three months of
age coincides with the initial detection of histopathology in several
murine models of OA. To determine OA status, selected tissues were
stained with Safranin O to identify proteoglycans and counterstained
with Fast Green. The extent of staining and onset of OA were quantiﬁed
using Modiﬁed Mankin and OARSI scoring systems. Selected tissue
sections of each genotypewere also stained immunohistochemically for
the presence of TGFß1, the inﬂammatory mediator that has been
identiﬁed to play a role in OA progression.
Results: The results revealed Mankin and OARSI scores consistent with
OA-like changes. These changeswere detectable as early as threemonths
in Dmm/þ mice when compared with normal joint biology observed in
control animals. Compared to basal expression in control TMJs and knee
joints, staining for TGFß1 demonstrated augmented expression in Dmm/
þmice as early as threemonths of age, with overexpression persisting in
six-month-old mutant mice, but then disappearing at nine months of
age. The present study demonstrated that TGFß1 was overexpressed in
TMJ and knee articular cartilage of three- and six-month-old Dmm/þ
mice when compared with age-matched controls.
Conclusions: Early TGFb1 expression levels suggested that this
inﬂammatory mediator is involved in the earliest stages of TMJ OA.
Further studies are underway that could shed light on TGFB1 and the
use of other inﬂammatory markers such as HtrA1 and SMADs as pos-
sible targets for therapeutic intervention.
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ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM INTRODUCES
OSTEOARTHRITIS
K. Yamagishi, I. Tsukamoto, M. Akagi. Kinki Univ., Osakasayama City,
Osaka, Japan
Purpose: In 2013, we reported that the local renin-angiotensin system
(RAS) can modulate the hypertrophic differentiation of chondrocytes.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A321The current study aimed to investigate whether hyperactivation of the
RAS inﬂuences OA using forced-running mice models.
Methods: C57/BL6 mice and Tsukuba hypertensive mice (THM) were
forced to run (25m/min, 30 min/day, 5days/week) (n¼10). OA histo-
pathology was analyzed using the OARSI score at 0, 2, 4, 6, and 8 weeks.
Expression of type II collagen, type X collagen, MMP-13, ADAM-TS5 and
some RAS components were also analyzed.
Results: The OARSI scores of the lateral femoral condyles were sig-
niﬁcantly higher in the THM than in the C57BL/6 mice at 4, 6 and 8
weeks. However, in medial femoral condyles, there were not signiﬁcant
differencesbetween C57/BL6mice and THM. At 8 weeks, type II collagen
was stained in a lower number of chondrocytes in the THM than C57/
BL6 mice. The expression of type X collagen, MMP-13 and ADAM-TS5
was conﬁrmed in the THM, but not in the C57/BL6 mice. In the THM, we
compared the expression of angiotensin II type 1 receptor (AT1R) and
AT2R at each week. At 0 weeks, we could not conﬁrm the expression of
AT1R and AT2R. However, we conﬁrmed the expression of AT1R and
AT2R at 2, 4, 6, 8 weeks.
Conclusions:We conﬁrmed that the hyper activation of RAS induces OA




PRESENCE OF INTERLEUKIN-17 IN OSTEOARTHRITIS: DOES IT
INDICATE A DIFFERENT OSTEOARTHRITIS PHENOTYPE
A. Lubbeke, S. Bas, G.J. Puskas, D. Suva, A. Finckh, C. Gabay,
P. Hoffmeyer. Geneva Univ. Hosp., Geneva, Switzerland
Purpose: Interleukin-17 (IL-17) is an important factor in the patho-
genesis of autoimmune diseases and allergy, and IL-17 antagonists are
currently evaluated in randomized trials with encouraging results. In
OA IL-17 contributes to cartilage breakdown and synovial infiltration by
inducing the release of chemokines by chondrocytes and synovial
fibroblasts independent of the IL-1 and TNF-a pathway. It also affects
cartilage matrix turnover, induces angiogenesis in articular tissue, and
ampliﬁes joint inﬂammation. However, IL-17 is only infrequently
detected in OA and clinical studies are sparse.
We aimed at evaluating the relation between absence or presence of IL-
17 in synovial ﬂuid (SF) of patients with endstage knee and hip OA and
(1) other (adipo-)cytokine SF concentrations, and (2) clinical and
radiographic disease parameters.
Methods: Cross-sectional study including patients prior to total hip
(THA) and knee arthroplasty (TKA) operated upon for primary OA at a
large tertiary hospital between January and December 2010. The
morning of surgery concentrations of IL-17, IL-6, leptin, visfatin, adi-
ponectin, resistin, MCP-1, MCP-3 and NGF were sampled from synovial
ﬂuid and assessed using ELISA kits. Baseline characteristics recorded
preoperatively included age, sex, BMI, co-morbidities, pain and function
(WOMAC), and radiographic analyses (OA features, K&L grade, minimal
JSW).
Results: 152 patients were included, 68 prior to THA and 84 to TKA.
Mean age was 73 (±9) years, 64% were women. In 14 patients (9.2%) IL-
17was present in the SF (median concentration 7.9 pg/ml, IQR 1.6; 20.6).
These patients had signiﬁcantly higher median SF concentrations of IL-
6, leptin, resistin, MCP-3 and b-NGF, and a tendency to be female,
younger, and obese class II, as compared to those without IL-17.
Radiographic analyses revealed a signiﬁcantly reduced minJSW
together with a lower proportion of sclerosis and osteophytes in the
presence of IL-17 in SF. No differences were found with respect to pain,
function and comorbidities. There was a moderate correlation between
Il-17 concentrations in SF and serum (r¼0.482).
Conclusions: The presence of IL-17 in SF of patients with primary end
stage OA was associated with high levels of several other proin-
ﬂammatory adipokines, cytokines and chemokines, and with a different
radiographic OA feature pattern. Moreover, patients tended to be
younger, more oftenwomen and obese class II. Our results may indicate
a different OA phenotype with a potential for a new treatment option.511
ASSOCIATIONS BETWEEN KNEE PAIN SEVERITY AND PROGRESSION
VERSUS MRI FEATURES: THE VANCOUVER LONGITUDINAL STUDY
OF EARLY KNEE OA
E.C. Sayre y, A. Guermazi z, J.M. Esdaile x, J.A. Kopec x, H. Wong x,
J. Singer x, A. Thorne x, S. Nicolaou x, J. Cibere x. yArthritis Res. Ctr. of
Canada, Richmond, BC, Canada; zBoston Univ. Med. Campus, Boston,
MA, USA; xUniv. of British Columbia, Vancouver, BC, Canada
Purpose: To determine the associations between knee pain severity and
progression versus MRI features, including cartilage, osteophytes, bone
marrow lesions (BML), subchondral sclerosis, meniscus, subchondral
cysts and effusion, in a population-based cohort with knee pain.
Methods: Baseline, mean 3.3- and mean 7.5-year follow-up MRI
assessments of the study (painful) knee were performed for 122 sub-
jects with baseline knee pain, age 40-79 at baseline, sample-weighted
for population (with knee pain) representativeness in Vancouver, BC
(the Vancouver Longitudinal Study of Early Knee OA). MRIs were
acquired on a 1.5Tmagnet at a single centre using a transmitter-receiver
extremity knee coil, and 3 planes double-echo weighted sequences
with and without fat suppressionwere obtained. MRIs were scored by a
single experienced reader for cartilage (0¼normal to 4¼full thickness
defect; 0/1 collapsed to 1¼only signal change), BML (0¼absent to
3¼severe), subchondral sclerosis (0¼absent to 3¼severe) and sub-
chondral cyst (0¼absent to 3¼severe) in 6 regions: lateral and medial
femur, lateral and medial tibia, patella and trochlear groove. Meniscus
(0¼normal to 3¼maceration/resection) was also scored in 6 regions:
lateral anterior, lateral body, lateral posterior, medial anterior, medial
body and medial posterior. Osteophytes (0¼absent to 3¼large) were
scored in 8 regions: lateral and medial femur, lateral and medial tibia,
and lateral, medial, superior and inferior patella. For each feature,
region scores were added up and the sum divided by the number of
regions. Effusion (0¼absent to 3¼severe) was scored for the overall
knee and included as an indicator for >¼2. Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) knee pain scale
(normalized 0-100; higher numbers worse) was administered at each
time point.
Cross-sectional models of pain were ﬁt on 3 time points simultaneously
(N¼366), using generalized estimating equations (GEE) to account for
correlated data. Longitudinal (change) models of delta pain, and indi-
cators for 10þ points increase in pain, and 20þ points increase in pain
were ﬁt on both 2-cycle changes simultaneously (cycles 1-2 and 2-3;
N¼244), using GEE for binary or linear regression. Models for each
feature were adjusted for age, sex and BMI (and follow-up time for
longitudinal models).
Results: 55.7% of the weighted sample was female. At baseline, mean
BMI was 26.1 and mean age was 55.5. Mean divided score sums at
baseline were 1.74 for cartilage, 0.93 for osteophytes, 0.27 for BML, 0.08
for subchondral sclerosis, 0.48 for meniscus and 0.06 for subchondral
cysts. Average normalized WOMAC pain at baseline was 19.1. 29.6% had
baseline effusion >¼2. Spearman rank correlations among the seven
MRI features were all signiﬁcantly >0, ranging from 0.21 (meniscus vs.
subchondral cyst) to 0.68 (osteophyte vs. cartilage).
In cross-sectional regression models, osteophytes were signiﬁcantly
associated with pain (coefﬁcient¼7.17; 95% CI¼3.19, 11.15), as was
subchondral sclerosis (11.03; 0.68, 21.39). In longitudinal linear models
of delta pain score, cartilage and osteophytes were signiﬁcantly asso-
ciated with pain change, respectively 4.31 (0.67, 7.95) and 4.51 (0.53,
8.49). In longitudinal binary models of delta pain score >¼10, osteo-
phytes (OR¼3.20; 1.36, 7.55), subchondral sclerosis (OR¼5.69; 1.06,
30.44), meniscus (OR¼1.68; 1.08, 2.61) and effusion >¼2 (OR¼2.25;
1.07, 4.71) were signiﬁcantly associated with pain increase. Finally, in
binary models of delta pain score >¼20, cartilage and osteophytes were
signiﬁcantly associated with pain increase, respectively OR¼2.42 (1.24,
4.74) and 3.79 (1.41, 10.20). No associations were observed between
pain severity or pain progression and BML or subchondral cysts, after
adjusting for age, sex and BMI.
Conclusions: In this population-based cohort with 7-year follow-up we
found a positive association between knee pain severity and both
